Driving Sustainable Value Through Pharmaceutical Innovation
At Marigold Pharma, our commitment to shareholder value is anchored in scientific rigor, cGMP-compliant manufacturing, global CDMO partnerships, and disciplined financial stewardship. We provide transparent access to our corporate disclosures, financial reports, and governance frameworks.
Disclosures & Financial Reports
Operating Sheets & Results
Review our quarterly performance sheets, key operational metrics, revenue breakdowns, and financial disclosures.
Corporate Governance
Our governance framework ensures accountability, transparency, ethical compliance, and robust risk management for all stakeholders.
Investor Communications
Direct communication channel for shareholders, analysts, institutional investors, and compliance inquiries.
Financial Filings & Operating Releases
| Period / Filing Title | Type | Release Date | Action |
|---|---|---|---|
| FY 2025-26 Annual Financial Statement Consolidated Annual Accounts & Auditor Disclosures |
Financial Report | July 2026 | View Statement |
| Quarterly Operating Sheet (Q3) Key Operating Performance & Capacity Utilization |
Operating Sheet | January 2026 | View Sheet |
| CDMO & Formulation Capacity Expansion Update Investor Presentation on Solapur MIDC Facility |
Presentation | November 2025 | View Presentation |
Investor Relations & Compliance Desk
For inquiries regarding shareholding, financial disclosures, or stakeholder communications, please reach out to our dedicated investor office.
Plot C 23, Chincholi MIDC Solapur — 413255, Maharashtra, India